Archive · 2 Jun 2025
India Lacks Access to Antibiotics Amidst Superbug Spread
Imagine tiny germs that are becoming super strong and not responding to usual medicines, which is a huge problem!
A recent study shows that in places like India, people are getting sick from these superbugs but can't always get the medicines they need to get better.
Even though India has a lot of these infections, many people don't get the right treatment.
This is because the medicine may be too expensive, hard to get, or not available.
Experts say we need to stop using antibiotics when we don't need them and also find ways to make sure everyone can get the medicines they really do need.
This will help prevent more people from getting very sick.
Study reveals limited access to life-saving antibiotics in low- and middle-income countries despite rising superbug infections.
India has a significant burden of carbapenem-resistant Gram-negative (CRGN) bacteria cases but low treatment rates.
Reasons for lack of treatment include difficulties in reaching appropriate healthcare, inaccurate diagnoses, lack of access, and high drug costs.
Experts emphasize the need for policies to prevent antibiotic misuse and improve drug affordability and availability.
India's pharmaceutical sector has the potential to lead in developing new drugs and diagnostics.
- Who
- Study led by the Global Antibiotic Research and Development Partnership (GARDP) and experts.
- What
- Study highlights the limited access to antibiotics for treating CRGN infections in low- and middle-income countries.
- When
- Study was published on June 2, 2025.
- Where
- Study focuses on eight low- and middle-income countries, including India.
- Why
- Patients are missing out on treatment due to challenges like reaching healthcare, diagnosis, access, and cost.
- Study Focus
- CRGN infections in 8 low- and middle-income countries
- CRGN Cases
- Nearly 1.5 million cases studied
- Countries Studied
- India, Brazil, South Africa, and others
- Treatment Rate
- 6.9% of patients in the study received the right treatment
- India's Burden
- Highest number of cases among countries studied
- India Treatment Rate
- 7.8% of people with CRGN infections received the right treatment
- Key Issues
- Drug supply gap, high costs, misuse of antibiotics